High-Blood-Pressure Medication Shows Protective Effect for Brain Structure and Function

August 4, 2017 - Toronto, CA – A new study from Sunnybrook researchers provides evidence that a specific type of treatment for hypertension, or high blood pressure, appears to protect against brain degeneration associated with Alzheimer’s disease, and preserve cognition when compared to other classes of anti-hypertensive medications. More...

August 4, 2017

Two New Studies Offer Insights into Gastrointestinal Dysfunction in Parkinson’s Patients

Research in the latest issue of the Journal of Parkinson’s Disease examines intestinal dysfunction and constipation

August 4, 2017 - Amsterdam, NL – Constipation is one of the most common non-motor related complaints affecting Parkinson’s disease (PD) patients. Two important studies from the same research group published in the Journal of Parkinson’s Disease expand the understanding of the relationship between PD and gastrointestinal dysfunction. In one study, investigators measured actual colonic dysfunction and compared it to reported constipation. In the other study, researchers tracked the position of an ingested wireless electromagnetic capsule using the novel 3D-Transit system in order to calculate gastrointestinal (GI) regional transit times. More...

August 4, 2017

Training Can Improve Athletes’ Stereo Vision

Significant Effects Can Persist for Some Time, Reports Restorative Neurology and Neuroscience

July 5, 2017 - Amsterdam, NL – Stereo vision allows individuals to perceive depth differences in their surroundings. Important to pedestrians and drivers, for example, depth perception plays a key role in many sporting activities. If the ability to accurately determine the distance and speed of a fast-moving object can be improved, athletes have the potential to improve their performance. In a new study published in Restorative Neurology and Neuroscience, researchers found that by training athletes using repetitive stereoscopic stimuli, their reaction speed to those stimuli could be significantly improved. More...

July 5, 2017

Anti-Epilepsy Drug Restores Normal Brain Activity in Mild Alzheimer’s disease

Feasibility study suggests suppressing seizure-like activity may help patients.

June 29, 2017 - Boston, USA – In the last decade, mounting evidence has linked seizure-like activity in the brain to some of the cognitive decline seen in patients with Alzheimer’s disease. Patients with Alzheimer’s disease have an increased risk of epilepsy and nearly half may experience subclinical epileptic activity – disrupted electrical activity in the brain that doesn’t result in a seizure but which can be measured by electroencephalogram (EEG) or other brain scan technology. More...

June 29, 2017